UNM Comprehensive Cancer Center
UNM Comprehensive Cancer Center is the only NCI-designated cancer center in New Mexico, providing chemotherapy, surgery, radiation, immunotherapy, and clinical trials to cancer patients statewide as part of UNM Health System.
- Company typePublic
- Founded1971
- HeadquartersAlbuquerque, United States
- Headcount501–1,000
- GTM typeB2C
- OfferingServices
What UNM Comprehensive Cancer Center does
UNM Comprehensive Cancer Center is the only National Cancer Institute-designated cancer center in New Mexico, operating as a public academic medical center within the University of New Mexico Health Sciences Center. The center provides comprehensive cancer care spanning medical oncology, surgical oncology, radiation oncology, immunotherapy, chemotherapy, and clinical trials, serving patients across New Mexico who would otherwise need to leave the state for NCI-level care. Care is delivered through a dedicated cancer facility at 1201 Camino de Salud NE in Albuquerque and integrated into a larger delivery network that includes UNM Hospital (New Mexico's only Level 1 trauma center), UNM Sandoval Regional Medical Center, UNM Children's Hospital, and 76 outpatient clinic locations under UNM Medical Group.
The underlying technology stack is conventional enterprise healthcare IT rather than proprietary platform infrastructure: Cerner Millennium EMR serves as the enterprise electronic medical record for the broader UNM Health System, while MOSAIQ Oncology EMR provides oncology-specific treatment planning and off-campus access for practitioners. Patient access is supported by centralized scheduling, provider referral portals (including a Provider Portal for referring physicians), and 25 documented telehealth offerings that extend oncology reach into rural and tribal communities across the state. Patient engagement tools include the UNM Health mobile wayfinding app and the MyHealthUNM patient portal.
Revenue is generated primarily through fee-for-service patient care billed under CMS-compliant standard charge schedules, with gross charges, payer-negotiated rates, and cash prices publicly disclosed for price transparency. Cost estimates are available through a Self-Service Patient Estimate tool, and financial assistance programs address uninsured populations. Research revenue flows through the NCI Cancer Center Support Grant and consortium-based funding, including an initial $40M allocation to UNM CCC as part of the C-Further international pediatric oncology consortium in partnership with UVA Comprehensive Cancer Center, Dana-Farber Cancer Institute, Mass General Brigham, MiNK Therapeutics, University of Southampton, Cancer Research Horizons, LifeArc, and Great Ormond Street Hospital Charity. UNM Health reports 1M+ patient visits annually, and the broader system employs 1,627 providers, of which UNM Medical Group contributes 1,100+ practitioners across 152 specialties.
UNM Comprehensive Cancer Center firmographics
Firmographics- Name
- UNM Comprehensive Cancer Center
- Legal name
- UNM Health System
- Website
- https://unmhealth.org
- Company type
- Public
- Founded year
- 1971
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- UNM Comprehensive Cancer Center is the only NCI-designated cancer center in New Mexico, providing chemotherapy, surgery, radiation, immunotherapy, and clinical trials to cancer patients statewide as part of UNM Health System.
- Ownership category
- akta.pro rank
UNM Comprehensive Cancer Center industry classification
Industry- Product category
- Oncology/Cancer Care Services
- NAICS
- Ambulatory Health Care Services (621), Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Offices of Physicians (62111)
- SIC
- Services-Specialty Outpatient Facilities, Nec (8093), Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)
- akta.pro primary industry
- Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)
- akta.pro secondary industries
- Oncology & Cancer Specialty Hospitals (HLAFAHAC), Medical Oncology (HLAKAFAB)
Keywords
Where UNM Comprehensive Cancer Center is headquartered
LocationHeadquarters
- HQ city
- Albuquerque
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
UNM Comprehensive Cancer Center business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Patient Care Services: Healthcare services provided to patients including inpatient, outpatient, emergency, and specialty care. UNM Hospital serves 1M+ patient visits annually as New Mexico's only Level 1 trauma center.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Standard hospital charges published for transparency |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels4 records
UNM Comprehensive Cancer Center product offering
Product offeringCore offering
The UNM Comprehensive Cancer Center is the only NCI-designated cancer center in New Mexico, providing comprehensive cancer treatment (chemotherapy, surgery, radiation therapy, immunotherapy), clinical trials, cancer research, survivorship care, and support services. It operates as the oncology specialty hub of the UNM Health Sciences Center, delivering academic, research-backed cancer care to patients across the state, including rural and Native American communities.
Product overview
UNM Comprehensive Cancer Center is a single healthcare service offering - an NCI-designated cancer center that provides comprehensive cancer treatment, research, and clinical care services to patients in New Mexico. It operates as part of the UNM Health System.
Differentiator
Problem solved
Functional benefit
Products and services
- Comprehensive Cancer Treatment Services Comprehensive cancer care including medical oncology, surgical oncology, radiation oncology, immunotherapy, and chemotherapy provided at the only NCI-designated cancer center in New Mexico. For adult and pediatric patients throughout the state.
- Clinical Trials Access to National Cancer Institute-sponsored oncology clinical trials, including pediatric programs such as C-Further CF-012 for Ewing sarcoma and CF-033 for bone sarcoma, medulloblastoma, and acute myeloid leukemia. Open to qualifying cancer patients in New Mexico.
- Cancer Survivorship and Support Services Post-treatment survivorship care, patient navigation, and support services for cancer patients and families. Designed for patients completing cancer treatment at UNM Comprehensive Cancer Center.
- Oncology Telehealth Services 25 telehealth offerings enabling remote oncology consultations and follow-up care for cancer patients across New Mexico, particularly serving rural and Native American communities who otherwise lack local specialty access.
- 24/7 Emergency and ICU Cancer Care 24/7 emergency and ICU expertise for complex oncology emergencies at New Mexico's only Level 1 trauma center, part of UNM Hospital. For cancer patients requiring emergency intervention across the region.
Quantifiable outcome
- 1M+ patient visits annually across UNM Health System
Companies that use UNM Comprehensive Cancer Center
Customer profileNamed customers2 records
Segments2 records
Ideal customer profiles2 records
UNM Comprehensive Cancer Center technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
UNM Comprehensive Cancer Center partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core.
- UVA Comprehensive Cancer CentercoreC-Further consortium partnered with UVA Comprehensive Cancer Center for CF-012 pediatric oncology program targeting Ewing sarcoma. This is part of an international consortium dedicated to childhood cancer therapeutics with an initial $40 million budget.
- Dana-Farber Cancer InstitutecoreC-Further consortium partnered with Dana-Farber Cancer Institute for CF-012 pediatric oncology program targeting Ewing sarcoma. Dana-Farber provides clinical expertise for the pediatric oncology research consortium.
- Mass General BrighamcoreC-Further consortium partnered with Mass General Brigham for CF-012 pediatric oncology program targeting Ewing sarcoma, contributing to the international childhood cancer therapeutics initiative.
- MiNK TherapeuticscoreC-Further consortium partnered with MiNK Therapeutics for CF-033 pediatric oncology program targeting multiple children's cancers including bone sarcoma, medulloblastoma, and acute myeloid leukemia.
- University of SouthamptoncoreC-Further consortium partnered with University of Southampton for CF-033 pediatric oncology program. The consortium is supported by core partners Cancer Research Horizons, LifeArc, and Great Ormond Street Hospital Charity.
- Cancer Research HorizonscoreCore supporting partner of C-Further international consortium dedicated to childhood cancer therapeutics with an initial budget of $40 million (£30 million).
- LifeArccoreCore supporting partner of C-Further international consortium dedicated to childhood cancer therapeutics with an initial budget of $40 million (£30 million).
- Great Ormond Street Hospital CharitycoreCore supporting partner of C-Further international consortium dedicated to childhood cancer therapeutics with an initial budget of $40 million (£30 million).
Scale indicators7 records
Recent moves5 records
Expansion highlights5 records
UNM Comprehensive Cancer Center competitors and assessment
Company assessmentBroad incumbents
- Stanford Cancer Institute: NCI-designated Comprehensive Cancer Center within a large academic medical system. Comparable to UNM in NCI designation and academic model, with a broader portfolio of subspecialty oncology services and a national referral base.
Direct peers
- Fred Hutchinson Cancer Center: NCI-designated Comprehensive Cancer Center affiliated with UW Medicine, focused on translational research, immunotherapy, and clinical trials. Comparable to UNM in NCI-designation scope and academic medical-center integration.
- Mayo Clinic Comprehensive Cancer Center: NCI-designated Comprehensive Cancer Center integrated within an academic medical system, offering the same medical, surgical, and radiation oncology plus clinical-trial portfolio as UNM, with a multi-state geographic footprint.
- Memorial Sloan Kettering Cancer Center: NCI-designated Comprehensive Cancer Center specializing in multidisciplinary oncology care, translational research, and clinical trials. Closest functional peer to UNM Comprehensive Cancer Center in terms of care model and research orientation.
- Huntsman Cancer Institute: NCI-designated Comprehensive Cancer Center at the University of Utah serving a primarily rural Western catchment. Closely comparable to UNM in academic medical center structure, NCI designation, and geographic reach into underserved populations.
- Roswell Park Comprehensive Cancer Center: NCI-designated Comprehensive Cancer Center operating as a standalone specialty hospital. Comparable to UNM Comprehensive Cancer Center in research-driven oncology services, clinical trials, and multidisciplinary care.
- Duke Cancer Institute: NCI-designated Comprehensive Cancer Center integrated within an academic medical center. Comparable to UNM Comprehensive Cancer Center in combining research, clinical trials, and multidisciplinary oncology care.
- Dana-Farber Cancer Institute: NCI-designated Comprehensive Cancer Center affiliated with Harvard Medical School and a C-Further consortium partner of UNM. Comparable as a research-intensive oncology center providing clinical trials and subspecialty cancer care.
- MD Anderson Cancer Center: NCI-designated Comprehensive Cancer Center and academic oncology institution. Directly comparable as a research-driven cancer center providing medical, surgical, and radiation oncology plus clinical trials, though operating at a far larger national scale.
- University of Virginia Cancer Center: NCI-designated cancer center and a C-Further consortium partner of UNM. Directly comparable as a university-affiliated oncology program providing clinical trials and multidisciplinary cancer care.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
UNM Comprehensive Cancer Center social profiles
Digital presenceUNM Comprehensive Cancer Center financial estimates
Financial estimateRevenue estimate
Valuation estimate
UNM Comprehensive Cancer Center leadership team
Management profileNumber of profiles
UNM Comprehensive Cancer Center subsidiaries and ownership
Company hierarchySubsidiaries5 records
UNM Comprehensive Cancer Center funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
UNM Comprehensive Cancer Center M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about UNM Comprehensive Cancer Center
What does UNM Comprehensive Cancer Center do?
The UNM Comprehensive Cancer Center is the only NCI-designated cancer center in New Mexico, providing comprehensive cancer treatment (chemotherapy, surgery, radiation therapy, immunotherapy), clinical trials, cancer research, survivorship care, and support services. It operates as the oncology specialty hub of the UNM Health Sciences Center, delivering academic, research-backed cancer care to patients across the state, including rural and Native American communities.
Is UNM Comprehensive Cancer Center a public or private company?
UNM Comprehensive Cancer Center is a public company. It is classified as state government owned and is currently operating.
When was UNM Comprehensive Cancer Center founded?
UNM Comprehensive Cancer Center was founded in 1971. It employs 501 to 1,000 people.
Where is UNM Comprehensive Cancer Center based?
UNM Comprehensive Cancer Center is headquartered in Albuquerque, United States, in the North America region.
How does UNM Comprehensive Cancer Center make money?
One revenue line is on record: patient Care Services.
Who are UNM Comprehensive Cancer Center's main competitors?
Stanford Cancer Institute is listed as a broad incumbent. Direct peers are Fred Hutchinson Cancer Center, Mayo Clinic Comprehensive Cancer Center, Memorial Sloan Kettering Cancer Center, Huntsman Cancer Institute, Roswell Park Comprehensive Cancer Center, Duke Cancer Institute, Dana-Farber Cancer Institute, MD Anderson Cancer Center and University of Virginia Cancer Center.
Does UNM Comprehensive Cancer Center have an API?
No public API is recorded for UNM Comprehensive Cancer Center.
What industry is UNM Comprehensive Cancer Center in?
UNM Comprehensive Cancer Center's product category is Oncology/Cancer Care Services. Its primary akta.pro industry code is HLAFABAI, Ambulatory Oncology Centers (Outpatient Chemo/Radiation), with a secondary code of HLAFAHAC, Oncology & Cancer Specialty Hospitals. Its NAICS code is 621 and its SIC code is 8093.